Market Wire - First Clinical Trial to Demonstrate Colesevelam HCl Plus Stable Oral Antidiabetic Medication Improves Glycemic Control in Patients With Type 2 Diabetes
June 10, 2006 -- The first data to demonstrate the effect ofWelChol® (colesevelam hydrochloride) on glucose lowering was presentedtoday at The American Diabetes...
Market Wire - First Data to Show Addition of a Bile Acid Sequestrant (WelChol, colesevelam HCl) to Statin Therapy Significantly Reduces Median hs-CRP Levels
April 18, 2006 -- Data published today in the April 15 issueof the American Journal of Cardiology demonstrated that adding WelChol®(colesevelam hydrochloride) to...
Southern Medical Journal - Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.(Review Article)
March 1, 2006 -- Abstract: Bile acid sequestrants (BAS) continue to command a position in the treatment of dyslipidemias 25 years after their introduction. Partial...
Journal of Family Practice - What are effective medication combinations for dyslipidemia?
January 1, 2006 -- EVIDENCE-BASED ANSWER Many combination drug therapies are effective in treating dyslipidemia, Compared with statin monotherapy, combinations that...
Business Wire - Sankyo Pharma Inc. Announces Its Second Cardiovascular Product Launch
April 26, 2002 -- Business Editors PARSIPPANY, N.J.--(BUSINESS WIRE)--April 26, 2002 Sankyo Pharma: FDA Grants Marketing Approval to Benicar(TM) (olmesartan...
Chemical Market Reporter - Genzyme General Acquires GelTex Pharmaceuticals for $1 Billion.(Brief Article)
September 18, 2000 -- TO BOOST ITS short-term pipeline, Genzyme General, the biotechnology division of Genzyme Corporation, has agreed to acquire GelTex Pharmaceuticals...
Market Wire - Treatment With WelChol(R) (Colesevelam Hydrochloride) May Lead To Increased LDL Particle Size For Patients With Moderate Hypercholesterolemia
January 1, 1970 -- Sankyo Pharma Inc. announced today that WelChol, at the recommendedstarting daily dosage (3.8g), significantly increased low-densitylipoprotein -...
